A recent report reveals critical gaps in gynaecological cancer care in Wales, putting lives at risk. Despite a groundbreaking report two years ago exposing severe failures, improvements have been slow and insufficient. Among the heart-breaking stories is that of Claire O’Shea and Judith Rowlands, whose symptoms were dismissed until it was too late. Both have since tragically passed away, highlighting urgent issues in the system.
Claire was initially misdiagnosed with IBS, only to find out later she had advanced uterine leiomyosarcoma. Her story, alongside Judith’s, who died from endometrial cancer, underscores the pressing need for change. Claire used her final years to fight for better awareness and treatment of gynaecological cancers, but change has been minimal.
Statistics are dire: by October 2025, only 41% of patients started treatment within the 62-day target. The follow-up report criticises the Welsh Government for not implementing several key recommendations, including the lack of ring-fenced funding and measurable NHS targets for gynaecological cancers. Despite some funding announcements, many feel the pace of change is frustratingly slow.
Cancer charities and campaigners, including Tenovus Cancer Care and Claire’s Campaign, emphasise the absence of gynaecological cancers in the Women’s Health Plan as a glaring oversight. Target Ovarian Cancer voices similar concerns, with many contributors to the report feeling ignored.
Peter Fox MS, of the Health and Social Care Committee, calls the lack of progress “unacceptable,” stressing the real human cost behind every statistic. For real change, visible action, dedicated funding, and accountability are crucial. The journey towards improved gynaecological cancer care might be long, but it’s essential for the women and families affected. Let’s push for the changes these courageous women fought for. #Gynaecology #HealthcareReform #InMemoryOfClaireandJudith